Search results

Back
1 - 10 of 76 Search results
   05 September 2022  - 5 mins read

05 September 2022  - 5 mins read

‘A Life in a Day’: the realities of living with FOP

I was honored to be invited to take on the challenge to live ‘A Life in a Day of a patient with FOP’ – but also apprehensive. The challenge simulated a day spent living as someone who has fibrodysplasia ossificans progressiva (FOP). FOP is a debilita...

   03 May 2023

03 May 2023

02-2_Company-Fondation_Module 6 – Strategy_Raising rare disease awareness for future generations

...

   03 May 2023

03 May 2023

02-2_Company-Fondation_Module-6-–-Strategy_Raising-rare-disease-awareness-for-future-generations-1

...

   03 May 2023

03 May 2023

02-2_Company-Fondation_Module-6-–-Strategy_Raising-rare-disease-awareness-for-future-generations-2

...

   03 May 2023

03 May 2023

03-2_Sciences-Rare-Disease_Module-Banner-1

...

   19 April 2023

19 April 2023

04_2_HowWeHelpPeople_RARE-DISEASE_Nadine_200220_Ipsen_Berlin-0991

...

   18 April 2023

18 April 2023

2021 Sales

...

   12 February 2024  - 4 mins read

12 February 2024  - 4 mins read

Advocating for Yourself: L. Marie’s Experience with PBC

L. Marie started her career more than 20 years ago helping others access community health programs and healthcare—a skillset she never imagined would eventually be put to use advocating for her own health after being dismissed by her doctors.  ...

   05 June 2023

05 June 2023

Areas of focus

...

    -  18 November 2024

 -  18 November 2024

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay® from two Phase III ope...

1 2 3 … 8